Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBaronsmead 2vt Regulatory News (BMD)

Share Price Information for Baronsmead 2vt (BMD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 55.50
Bid: 54.00
Ask: 57.00
Change: 0.00 (0.00%)
Spread: 3.00 (5.556%)
Open: 55.50
High: 55.50
Low: 55.50
Prev. Close: 55.50
BMD Live PriceLast checked at -
Baronsmead Second Venture Trust is an Investment Trust

To achieve long-term investment returns for private investors by investing primarily in a diverse portfolio of UK growth businesses, whether unquoted or traded on AIM.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

11 Mar 2016 16:49

RNS Number : 9037R
Baronsmead VCT 3 PLC
11 March 2016
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR south africa OR any jurisdiction in which the same could be unlawful. the information contained herein does not constitute an offer of securities for sale in any jurisdiction, including in the united states, CANADA, australia, japan OR south africa.

BARONSMEAD VCT 3 PLC

11 MARCH 2016

ISSUE OF NEW SHARES IN CONNECTION WITH THE RECONSTRUCTION AND WINDING UP OF BARONSMEAD VCT 4 PLC AND OFFER FOR SUBSCRIPTION

Issue of New Shares pursuant to the Scheme

The Board of Baronsmead VCT 3 plc (the "Company") refers to the circular and prospectus published by the Company on 27 January 2016 in connection with, inter alia, the participation of the Company in the proposed scheme for the reconstruction and winding up of Baronsmead VCT 4 plc ("BVCT4"). 

The Board is pleased to announce that, following the passing of the resolutions at the general meeting of BVCT4 earlier today, the Company will acquire £70.68 million of assets of BVCT4 in consideration for the issue of New Shares to BVCT4 Shareholders. The portfolio of assets acquired is identical to the Company's current portfolio, with the exception of one unquoted investment and the investment in Wood Street which are held by the Company, but not BVCT4.

The number of New Shares to be issued to BVCT4 Shareholders under the BVCT4 Scheme will be based on the adjusted Net Asset Value of an Ordinary Share (the "FAV per Ordinary Share") and the adjusted Net Asset Value of a BVCT4 Share (the "FAV per BVCT4 Share"). The FAV per Ordinary Share and the FAV per BVCT4 Share were calculated as at close of business on 29 February 2016. The FAV per Ordinary Share was 103.94 pence and the FAV per BVCT4 Share was 96.58 pence. Accordingly, BVCT4 Shareholders will receive approximately 0.92919 New Shares for every BVCT4 Share.

Applications have been made for the New Shares to be issued pursuant to the Scheme to be admitted to the Official List (with a Premium Listing) and to the London Stock Exchange for the New Shares to be admitted to trading on the Main Market. It is expected that Admission will occur and dealings will commence in the New Shares to be issued pursuant to the Scheme at 8.00 a.m. on 16 March 2016.

Issue of New Shares pursuant to the Offer

The Board is also pleased to announce that the Company has raised gross proceeds of £10 million pursuant to the Offer set out in the prospectus.

New Shares issued under the Offer will be issued at an issue price of 107.2 pence. The issue price has been calculated by dividing the Company's latest published Net Asset Value of 103.94 pence as at 29 February 2016 by 0.97 in accordance with the pricing formula set out under the Offer.

Applications have been made for the New Shares to be issued pursuant to the Offer to be admitted to the Official List (with a Premium Listing) and to the London Stock Exchange for the New Shares to be admitted to trading on the Main Market. It is expected that Admission will occur and dealing will commence in the New Shares to be issued pursuant to the Offer at 8.00 a.m. on 16 March 2016. A further announcement is expected to be made on 15 March 2016 with respect the number of New Shares allotted under the Offer.

Changes to the Board

Following approval of the Proposals, Robert Owen and Malcolm Groat have joined the board of the Company as non-executive directors, with immediate effect. In addition, Gillian Nott OBE and Andrew Karney have retired as Directors of the Company. Save for as disclosed in the Prospectus, there are no other details to be disclosed pursuant to Listing Rule 9.6.13 in relation to this Board appointment. A copy of the Prospectus is available for inspection at the National Storage Mechanism, which is located at http://www.morningstar.co.uk/uk/NSM.

 

Change of Name

Following the Merger, the Company expects to change its name to "Baronsmead Second Venture Trust plc" on 14 March 2016. Trading is expected to commence on 15 March 2016 under the new name. The Company's ticker, ISIN and SEDOL will remain the same.

Definitions

Terms defined in the circular published by the Company dated 26 January 2016 have the same meanings in this announcement unless the context requires otherwise.

Further information

For further information please contact.

Michael Probin - VCT investor relationsLivingbridge VC LLP020 7506 5796

Notes

This announcement is for information purposes only and does not purport to be full or complete and any decision regarding the Proposals should be made only on the basis of the Circular and the Prospectus. 

This announcement does not constitute or form part of any offer to issue or sell, or any solicitation of any offer to subscribe or purchase, any investment in any jurisdiction, nor shall it (or the fact of its distribution) form the basis of, or be relied on in connection with, any contract therefor. 

The issue and the distribution of this announcement, the Circular and/or the Prospectus in certain jurisdictions may be restricted by law and persons into whose possession any document or other information referred to this announcement, the Circular and/or the Prospectus comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEQFLFFQXFZBBV
Date   Source Headline
6th Jun 20235:30 pmRNSNet Asset Value(s)
12th May 20237:00 amRNSCompliance with the Market Abuse Regulation
5th May 20235:30 pmRNSNet Asset Value(s)
4th May 20231:00 pmRNSNet Asset Value(s)
2nd May 202312:52 pmRNSTotal Voting Rights
5th Apr 20236:30 pmRNSTransaction in Own Shares
3rd Apr 20235:26 pmRNSTotal Voting Rights
3rd Apr 20233:49 pmRNSAllotment of Shares
3rd Apr 202311:11 amRNSTotal Voting Rights
30th Mar 202312:00 pmRNSNet Asset Value(s)
27th Mar 20235:23 pmRNSUpdate on Fundraising
14th Mar 20234:28 pmRNSAllotment of Shares
13th Mar 20235:44 pmRNSDirector/PDMR Shareholding
13th Mar 20235:43 pmRNSDirector/PDMR Shareholding
9th Mar 20236:25 pmRNSTransaction in Own Shares
9th Mar 20233:17 pmRNSUpdate on Fundraising
6th Mar 20234:45 pmRNSNet Asset Value(s)
1st Mar 20232:23 pmRNSTotal Voting Rights
24th Feb 20235:20 pmRNSUpdate on Fundraising
17th Feb 20236:16 pmRNSDirector/PDMR Shareholding
14th Feb 20237:00 amRNSTransaction in Own Shares
6th Feb 20235:00 pmRNSNet Asset Value(s)
1st Feb 20233:58 pmRNSDirector/PDMR Shareholding
1st Feb 20233:56 pmRNSResult of AGM
30th Jan 20235:38 pmRNSDirector/PDMR Shareholding
30th Jan 20235:36 pmRNSDirector/PDMR Shareholding
30th Jan 20233:05 pmRNSAllotment of Shares
27th Jan 202311:30 amRNSNet Asset Value(s)
3rd Jan 20234:50 pmRNSTotal Voting Rights
29th Dec 20224:56 pmRNSTransaction in Own Shares
16th Dec 202212:47 pmRNSPublication of a Prospectus
12th Dec 20224:45 pmRNSTransaction in Own Shares
6th Dec 20225:30 pmRNSNet Asset Value(s)
2nd Dec 20227:00 amRNSAnnual Financial Report
7th Nov 202211:30 amRNSNet Asset Value(s)
1st Nov 202211:21 amRNSTotal Voting Rights
14th Oct 20226:16 pmRNSTransaction in Own Shares- Correction
14th Oct 20224:45 pmRNSNet Asset Value(s)
4th Oct 202211:57 amRNSDirector/PDMR Shareholding
3rd Oct 20227:00 amRNSTotal Voting Rights
29th Sep 20226:32 pmRNSTransaction in Own Shares
13th Sep 20226:03 pmRNSTransaction in Own Shares
6th Sep 20225:45 pmRNSNet Asset Value(s)
1st Sep 20225:49 pmRNSTotal Voting Rights
16th Aug 20224:57 pmRNSTransaction in Own Shares
12th Aug 202211:44 amRNSIntention to Fundraise
4th Aug 20226:00 pmRNSNet Asset Value(s)
20th Jul 20227:00 amRNSNet Asset Value(s)
1st Jul 20223:44 pmRNSTotal Voting Rights
15th Jun 20227:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.